These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38 related articles for article (PubMed ID: 1965445)
1. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer. Spinazzi A; Soresi E; Boffi R; Nonis A; Noseda A; Cobelli S; Scanni A Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383 [TBL] [Abstract][Full Text] [Related]
2. Clinical value of neuron specific enolase and tissue polipeptidic antigen for the management of patients with lung cancer. Spinazzi A; Soresi E; Borghini U; Boffi R; Vigorelli R; Scoccia S J Nucl Med Allied Sci; 1990; 34(4 Suppl):141-5. PubMed ID: 1965446 [No Abstract] [Full Text] [Related]
3. Biomarkers and IL-2R in lung cancer. Marino P; Preatoni A; Fonticoli L; Parodi M; Tarolo GL Recenti Prog Med; 1990 Nov; 81(11):702-4. PubMed ID: 1962891 [TBL] [Abstract][Full Text] [Related]
4. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid. Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720 [TBL] [Abstract][Full Text] [Related]
5. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660 [TBL] [Abstract][Full Text] [Related]
6. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung]. De Angelis G; De Marinis F; Bigioni D; Migliorino MR; Alma MG; Pigorini F J Nucl Med Allied Sci; 1990; 34(4 Suppl):135-40. PubMed ID: 1965445 [No Abstract] [Full Text] [Related]
8. [Value of tumor markers in monitoring of cytotoxic treatment of non-small cell lung cancer]. Załeska M Pneumonol Alergol Pol; 2003; 71(7-8):359-64. PubMed ID: 15052970 [No Abstract] [Full Text] [Related]
9. [Tumor markers in lung cancer]. Niho S; Shinkai T Gan To Kagaku Ryoho; 2001 Dec; 28(13):2089-93. PubMed ID: 11791391 [TBL] [Abstract][Full Text] [Related]
10. [Tumor markers used in diagnosis and monitoring of primary bronchopulmonary carcinoma]. Mahler B Pneumologia; 2008; 57(3):175-7. PubMed ID: 18998332 [TBL] [Abstract][Full Text] [Related]
11. [Update regarding the role of biomarkers in early diagnosis of non-small cell bronchopulmonary cancer]. Dragomir A; Moldoveanu E; Mihălţan F Pneumologia; 2011; 60(1):7, 9-13. PubMed ID: 21548194 [TBL] [Abstract][Full Text] [Related]
12. [Tumor markers in the diagnosis and follow-up assessment of bronchial carcinoma]. Fischbach W Dtsch Med Wochenschr; 1989 May; 114(20):800-5. PubMed ID: 2656177 [No Abstract] [Full Text] [Related]